April 25, 2024 Postfracture Survival Rates Among Older Patients Rheumatic and Musculoskeletal Diseases
April 25, 2024 Leith Zakraoui, MD, Receives IOF’s 2024 CNS Medal Rheumatic and Musculoskeletal Diseases
April 25, 2024 Patricia Clark, MD, PhD, Awarded IOF’s 2024 CSA Medal of Achievement Rheumatic and Musculoskeletal Diseases
View Article April 25, 2024 Exploring Pain in Patients With Rheumatoid Arthritis and Little to No Synovial Inflammation Rheumatoid Arthritis Arthritis
View Article April 25, 2024 Preclinical Research Looks at Potential Factors Resulting in Fibrotic Interstitial Lung Disease and Therapeutic Targets Rheumatic and Musculoskeletal Diseases
View Program July 17, 2023 Change in Urinary Biomarkers at Three Months Predicts 1-Year Treatment Response of Lupus Nephritis Better Than Proteinuria
View Program July 17, 2023 Association Between Anti-Sjögren Syndrome/Scleroderma Autoantigen 1 (SSCA1) Antibodies and Cancer in Systemic Sclerosis
March 21, 2024 Residential Greenness May Be Correlated With Lower Osteoporosis Incidence Rheumatic and Musculoskeletal Diseases
March 21, 2024 Does Sinusitis Play Role in Development of Rheumatic Diseases? Rheumatic and Musculoskeletal Diseases
April 25, 2024 Preclinical Research Looks at Potential Factors Resulting in Fibrotic Interstitial Lung Disease and Therapeutic Targets Rheumatic and Musculoskeletal Diseases
April 25, 2024 Exploring Pain in Patients With Rheumatoid Arthritis and Little to No Synovial Inflammation Rheumatoid Arthritis Arthritis
April 25, 2024 Postfracture Survival Rates Among Older Patients Rheumatic and Musculoskeletal Diseases
April 30, 2024 Robotic Assistance May Not Reduce the Risk of Revision in Patients Undergoing Total Knee Arthroplasty Arthroplasty
April 25, 2024 Patricia Clark, MD, PhD, Awarded IOF’s 2024 CSA Medal of Achievement Rheumatic and Musculoskeletal Diseases
April 25, 2024 Leith Zakraoui, MD, Receives IOF’s 2024 CNS Medal Rheumatic and Musculoskeletal Diseases
April 17, 2024 Patient Advocate Offers Support and Health Information Through LupusChat Resource Lupus
Updates in Juvenile Idiopathic Arthritis: Novel Treatment Options Pave the Way for More Personalized patient-Centered Care
A Phase IV, Open-Label Study of Krystexxa (Pegloticase) Co-Administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)